Proposed Best Practice for Statisticians in the Reporting and Publication of Pharmaceutical Industry-Sponsored Clinical Trials
Pharmaceutical statistics 2011 Jan-Feb; 10(1): 70-3
In this paper we set out what we consider to be a set of best practices for statisticians in the reporting of pharmaceutical industry-sponsored clinical trials. We make eight recommendations covering: author responsibilities and recognition; publication timing; conflicts of interest; freedom to act; full author access to data; trial registration and independent review. These recommendations are made in the context of the prominent role played by statisticians in the design, conduct, analysis and reporting of pharmaceutical sponsored trials and the perception of the reporting of these trials in the wider community.
Showing items related by title, author, creator and subject.
Pyke, Stephen; Julious, Steven A; Day, Simon; O'Kelly, Michael; Todd, Susan; Matcham, James; Seldrup, Jorgen (2011-01)Concerns about potentially misleading reporting of pharmaceutical industry research have surfaced many times. The potential for duality (and thereby conflict) of interest is only too clear when you consider the sums of ...
Comments on 'The Potential for Bias in the Reporting of Industry Sponsored Clinical Trials' by Stephen Pyke Et Al. and 'Proposed Best Practice for Statisticians in the Reporting and Publication of Pharmaceutical Industry Sponsored Clinical Trials' by James Matcham Et Al. Pharmaceutical Statistics Campbell, M J (2011-01)